Mutually/RB
exclusive/JJ
interaction/NN
of/IN
a/DT
novel/JJ
matrix/NN
attachment/NN
region/NN
binding/NN
protein/NN
and/CC
the/DT
NF-muNR/NN
enhancer/NN
repressor/NN
./.
=====
Implications/NNS
for/IN
regulation/NN
of/IN
immunoglobulin/NN
heavy/JJ
chain/NN
expression/NN
./.

The/DT
immunoglobulin/NN
heavy/NN
chain/NN
(/(
IgH/NN
)/)
intronic/JJ
enhancer/NN
stimulates/VBZ
transcription/NN
from/IN
functional/JJ
promoters/NNS
in/IN
B/NN
lymphocytes/NNS
but/CC
not/RB
other/JJ
cell/NN
types/NNS
./.
=====
The/DT
observation/NN
that/IN
binding/VBG
sites/NNS
for/IN
the/DT
nuclear/JJ
factor-mu/NN
negative/JJ
regulator/NN
(/(
NF-muNR/NN
)/)
enhancer/NN
repressor/NN
overlap/VBP
nuclear/JJ
matrix/NN
attachment/NN
regions/NNS
(/(
MARs/NNS
)/)
in/IN
this/DT
enhancer/NN
has/VBZ
lead/VBN
to/TO
the/DT
hypothesis/NN
that/IN
the/DT
cell/NN
type/NN
specificity/NN
of/IN
the/DT
enhancer/NN
might/MD
be/VB
controlled/VBN
by/IN
regulating/VBG
nuclear/JJ
matrix/NN
attachment/NN
(/(
Scheuermann/NNP
,/,
R./NNP
H./NNP
,/,
and/CC
Chen/NNP
,/,
U./NNP
(/(
1989/CD
)/)
Genes/NNP
&/CC
Dev./NNP
3/CD
,/,
1255-1266/CD
)/)
./.
=====
To/TO
understand/VB
the/DT
role/NN
of/IN
MARs/NNS
in/IN
IgH/NN
enhancer/NN
regulation/NN
,/,
we/PRP
have/VBP
identified/VBN
a/DT
novel/JJ
MAR-binding/JJ
protein/NN
,/,
MAR-BP1/NN
,/,
from/IN
soluble/JJ
nuclear/JJ
matrix/NN
preparations/NNS
based/VBN
on/IN
its/PRP$
ability/NN
to/TO
bind/VB
to/TO
the/DT
MARs/NNS
associated/VBN
with/IN
the/DT
IgH/NN
enhancer/NN
./.
=====
Purified/VBN
MAR-BP1/NN
migrates/VBZ
as/IN
a/DT
33-kDa/JJ
protein/NN
,/,
and/CC
it/PRP
can/MD
be/VB
found/VBN
in/IN
nuclear/JJ
matrix/NN
preparations/NNS
from/IN
a/DT
number/NN
of/IN
different/JJ
types/NNS
of/IN
lymphoid/JJ
cell/NN
lines/NNS
./.
=====
Although/IN
specific/JJ
binding/VBG
sites/NNS
have/VBP
been/VBN
difficult/JJ
to/TO
localize/VB
by/IN
chemical/JJ
or/CC
enzymatic/JJ
footprinting/NN
procedures/NNS
,/,
NF-muNR/NN
binding/NN
sites/NNS
are/VBP
critical/JJ
for/IN
efficient/JJ
MAR-BP1/NN
binding/NN
./.
=====
Indeed/RB
,/,
binding/NN
of/IN
the/DT
IgH/NN
enhancer/NN
to/TO
either/CC
intact/JJ
nuclear/JJ
matrix/NN
preparations/NNS
or/CC
to/TO
MAR-BP1/NN
is/VBZ
mutually/RB
exclusive/JJ
to/TO
NF-muNR/NN
binding/NN
./.
=====
These/DT
results/NNS
are/VBP
consistent/JJ
with/IN
a/DT
model/NN
for/IN
cell-type/JJ
specific/JJ
regulation/NN
in/IN
which/WDT
binding/NN
of/IN
the/DT
NF-muNR/NN
repressor/NN
to/TO
the/DT
IgH/NN
enhancer/NN
prevents/VBZ
nuclear/JJ
matrix/NN
attachment/NN
in/IN
inappropriate/JJ
cells/NNS
by/IN
interfering/VBG
with/IN
MAR-BP1/enhancer/NN
interaction/NN
./.